Storer v. Clark
Court of Appeals for the Federal Circuit
1Opinion of the Court
NEWMAN, Circuit Judge.
This patent interference contest involves methods of treating hepatitis C by administering compounds having a specific chemical and stereochemical structure, based on the following foundation formula of a five-membered ring having the fluorine substi-tuent in the 2'(down) position:
[[Image here]]
Storer Br. at 8. The priority decision was based on enablement of this product. The interference was declared between an issued patent (Storer et al.) and a pending application (Clark), both of which were filed before the effective date of the America Invents Act, the statute that…
2Cases cited9 opinions
- Hybritech Incorporated v. Monoclonal Antibodies, Inc.Court of Appeals for the Federal Circuit · 1986
- Genentech, Inc. v. Novo Nordisk, A/s, Novo Nordisk of North America, Inc. And Novo Nordisk Pharmaceuticals, Inc.Court of Appeals for the Federal Circuit · 1997
- In Re Jack R. Wands, Vincent R. Zurawski, Jr., and Hubert J.P. SchoemakerCourt of Appeals for the Federal Circuit · 1988
- Streck, Inc. v. Research & Diagnostic Systems, Inc.Court of Appeals for the Federal Circuit · 2012
- Microsoft Corporation v. Proxyconn, Inc.Court of Appeals for the Federal Circuit · 2015
4 more not listed; retrieve them via the Exa API.
3Cited by9 opinions
- University of California v. Broad Institute, Inc.Court of Appeals for the Federal Circuit · 2018
- Idenix Pharmaceuticals LLC v. Gilead Sciences Inc.Court of Appeals for the Federal Circuit · 2019
- Colt Int'l Clothing Inc. v. Quasar Sci., LLCDistrict Court, C.D. California · 2018
- Hospira, Inc. v. Fresenius Kabi USA, LLCDistrict Court, E.D. Illinois · 2018
- Chevron U.S.A. Inc. v. University of Wyoming ResearchCourt of Appeals for the Federal Circuit · 2020
4 more not listed; retrieve them via the Exa API.